Stevanato Group S.p.A.

STVN

$20.94

Updated: 23/09/2026, 19:44:04

Market Cap

$5.72B

Sector

Healthcare

Industry

Medical - Instruments & Supplies

Country

Stock valuation chart

One-year closing share-price history for STVN

Company Profile

Stevanato Group S.p.A. is dedicated to engineering, manufacturing, and distributing integrated solutions for the pharmaceutical and healthcare sectors. Its core offerings span a wide array of products, including containment solutions, drug delivery systems, and medical devices, alongside diagnostic and analytical support. The company also produces specialized machinery for tasks such as visual inspection, assembly, packaging, and glass formation. Established in 1949, the company's main operations are situated in Piombino Dese, Italy, functioning as a subsidiary of Stevanato Holding S.R.L.

USD

NYSE

CEO: Franco Stevanato

Employees: 6,010

https://www.stevanatogroup.com

Asset Summaries

Latest generated summaries for STVN

No summaries found.

Detailed business

Structured knowledge from the latest official annual filing.

No official annual filing has completed ingestion for this company yet. The filing worker processes major-index companies incrementally and never repeats a completed fiscal year.

Full company information

Latest profile, trading, valuation, and identifier data stored for STVN.

Share price: $20.94
Market cap: $5.72B
Exchange: NYSE
Currency: USD
CEO: Franco Stevanato
Employees: 6,010
IPO date: 16/07/2021
Beta: 0.746
Last dividend: $0.00
Day range: $20.91 – $21.79
52-week range: $12.89 – $28.00
1-day performance: -3.53%
1-year performance: 62.41%
Current drawdown (1Y): -25.23%
CIK: 0001849853
CUSIP: T9224W109
ISIN: IT0005452658
Created: 07/12/2025, 14:26:05
Last update: 23/09/2026, 19:44:04

Track Stevanato Group S.p.A. with an AI analyst

See which prediction-market events move STVN, how its filings map to real-world exposure, and what 12 AI strategies are doing with positions like it.

Create a free account See what the world decides next

Free forever to follow AlphaBrain’s AI strategies. No card required.

Latest Database News

News linked to STVN from your Railway `news_articles` table.

Stevanato: HVS Momentum Overshadows Engineering Weakness, Offering Compelling Upside

Seeking Alpha • STOCK • 11/06/2026, 04:54:57

Stevanato Group Announces Results of Ordinary and Extraordinary Shareholders' Meeting

Business Wire • STOCK • 03/06/2026, 19:45:00

Implied Volatility Surging for Stevanato Stock Options

Zacks Investment Research • STOCK • 03/06/2026, 14:51:08

Stevanato Group S.p.A. (STVN) Presents at Bank of America Global Healthcare Conference 2026 Transcript

Seeking Alpha • STOCK • 12/05/2026, 16:00:50

Stevanato Group S.p.A. (STVN) Q1 2026 Earnings Call Transcript

Seeking Alpha • STOCK • 07/05/2026, 19:31:15

Stevanato Group to Participate in Three Upcoming Investor Conferences

Business Wire • STOCK • 04/05/2026, 19:45:00

Stevanato Group to Participate in the KeyBanc Capital Markets Virtual Healthcare Forum

Business Wire • STOCK • 12/03/2026, 17:45:00

Stevanato: Strong Q4 Results Reinforce Long-Term Growth Story

Seeking Alpha • STOCK • 06/03/2026, 05:28:43

Stevanato Group S.p.A. (NYSE:STVN) Overview and Financial Performance

Market Data • Market Data • 05/03/2026, 19:16:54

Stevanato Group S.p.A. (NYSE:STVN) Stock Update and Market Outlook

Market Data • Market Data • 05/03/2026, 17:03:48

Stevanato Group S.p.A. (STVN) Q4 2025 Earnings Call Transcript

Seeking Alpha • STOCK • 05/03/2026, 00:32:13

Stevanato Group (STVN) Surpasses Q4 Earnings and Revenue Estimates

Zacks Investment Research • STOCK • 04/03/2026, 09:46:10